Clinical Research Directory
Browse clinical research sites, groups, and studies.
Stereotactic Radiotherapy of Prostate Cancer With Reduction of Safety Margins
Sponsor: University Hospital Ostrava
Summary
The study aims to reduce the PTV (Planning Target Volume) safety margins to 1-2 mm in stereotactic prostate radiotherapy for low- and medium-risk prostate cancers while maintaining a dose of 36.25 Gy in 5 fractions per day. By reducing the hems, the investigators expect a reduction of acute and late toxicity on the organs at risk, dominantly the urethra, bladder, penile bulb, and rectum, and an improvement in the quality of life.
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2024-11-01
Completion Date
2027-12-31
Last Updated
2024-11-12
Healthy Volunteers
No
Conditions
Interventions
Stereotactic radiotherapy
Stereotactic surgery is a minimally invasive form of surgical intervention that makes use of a three-dimensional coordinate system to locate small targets inside the body and to perform on them some action such as ablation, biopsy, lesion, injection, stimulation, implantation, radiosurgery, etc.
Locations (1)
University Hospital Ostrava
Ostrava, Moravian-Silesian Region, Czechia